The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
Purpose: The purpose of this study was to determine the impact of splenic and thoracic bone marrow irradiation on hematologic toxicity in the setting of chemoradiation therapy for esophageal cancer. Methods and materials: We analyzed 60 patients with carcinoma of the distal esophagus or gastroesopha...
Main Authors: | Alexander L. Chin, MD, MBA, Sonya Aggarwal, BS, Pooja Pradhan, BS, Karl Bush, PhD, Rie von Eyben, MS, Albert C. Koong, MD, PhD, Daniel T. Chang, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109418300307 |
Similar Items
-
Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial
by: Akihiro Ohba, MD, et al.
Published: (2016-10-01) -
Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer
by: Margaret Montovano, MA, et al.
Published: (2021-05-01) -
Feasibility of definitive chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma: A retrospective study
by: Akinori Watanabe, MD, et al.
Published: (2018-07-01) -
18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
by: John M. David, MD, et al.
Published: (2019-10-01) -
Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer
by: Denise Fabian, et al.
Published: (2019-03-01)